A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas.

Clinical trial NCT00042666 · COMPLETED

Trial details

NCT number: NCT00042666
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma

Start date: 2002-06-01
Primary completion: 2008-09-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.